key: cord-0268778-k4jb14al authors: Suratekar, Rohit; Ghosh, Pritha; Niesen, Michiel J.M.; Donadio, Gregory; Anand, Praveen; Soundararajan, Venky; Venkatakrishnan, A.J. title: High diversity in Delta variant across countries revealed via genome-wide analysis of SARS-CoV-2 beyond the Spike protein date: 2021-09-02 journal: bioRxiv DOI: 10.1101/2021.09.01.458647 sha: 1c60f91d2ba9804ef013d61bc601b52b6b372fa3 doc_id: 268778 cord_uid: k4jb14al The highly contagious Delta variant of SARS-CoV-2 has emerged as the new dominant global strain, and reports of reduced effectiveness of COVID-19 vaccines against the Delta variant are highly concerning. While there has been extensive focus on understanding the amino acid mutations in the Delta variant ‘s Spike protein, the mutational landscape of the rest of the SARS-CoV-2 proteome (25 proteins) remains poorly understood. To this end, we performed a systematic analysis of mutations in all the SARS-CoV-2 proteins from nearly 2 million SARS-CoV-2 genomes from 176 countries/territories. Six highly-prevalent missense mutations in the viral life cycle-associated Membrane (I82T), Nucleocapsid (R203M, D377Y), NS3 (S26L), and NS7a (V82A, T120I) proteins are almost exclusive to the Delta variant compared to other variants of concern (mean prevalence across genomes: Delta = 99.74%, Alpha = 0.06%, Beta = 0.09%, Gamma = 0.22%). Furthermore, we find that the Delta variant harbors a more diverse repertoire of mutations across countries compared to the previously dominant Alpha variant (cosine similarity: meanAlpha = 0.94, S.D.Alpha = 0.05; meanDelta = 0.86, S.D.Delta = 0.1; Cohen ‘s dAlpha-Delta = 1.17, p-value < 0.001). Overall, our study underscores the high diversity of the Delta variant between countries and identifies a list of targetable amino acid mutations in the Delta variant ‘s proteome for probing the mechanistic basis of pathogenic features such as high viral loads, high transmissibility, and reduced susceptibility against neutralization by vaccines. The ongoing COVID-19 pandemic has infected over 210 million people and killed nearly 4.5 million people worldwide as of August 2021 1 . Throughout the pandemic, the SARS-CoV-2 virus has acquired novel mutations, and the US government SARS-CoV-2 Interagency Group (SIG) has classified the mutant strains as Variant of Concern (VOC), Variant of Interest (VOI), and Variant of High Consequence (VOHC) 2 . The variants of concern (Alpha, Beta, Gamma, and Delta) are more transmissible, cause more severe disease, and/or reduce neutralization by vaccines and monoclonal antibodies 2, 3 . The Delta variant (PANGO lineage B.1.617.2), first isolated from India in October 2020 3 , has emerged as the dominant global variant alongside the Alpha variant (PANGO lineage B.1.1.7), with genome sequences deposited from 104 and 150 countries, respectively, in the GISAID database 4 and has worsened the public health emergency 5, 6 . Recent studies are reporting nearly 1000-fold higher viral loads in infections associated with the Delta variant 7 and reduced neutralization of this variant by vaccines [8] [9] [10] [11] [12] . The NCBI database lists 26 proteins (structural, non-structural, and accessory proteins) in the SARS-CoV-2 proteome 13 totaling 9757 amino acids. These include four structural proteins (Spike, Envelope, Membrane, and Nucleocapsid), 16 non-structural proteins (NSP1-NSP16), and six accessory proteins (NS3, NS6, NS7a, NS7b, NS8, and ORF10). As of August 2021, the CDC identifies 11 amino acid mutations in the Spike protein of the Delta variant 2 , and the functional role of the SARS-CoV-2 Spike protein mutations has been well studied [14] [15] [16] . However, the mutational landscape of the rest of the Delta variant's proteome remains poorly understood. Concerted global genomic data sharing efforts through the GISAID database 4 have led to the availability of nearly 2 million SARS-CoV-2 genomes from over 175 countries/territories, thereby providing a timely opportunity to analyze the mutational landscape of SARS-CoV-2 variants across all the 26 proteins. Here, we perform a systematic analysis of amino acid mutations across the SARS-CoV-2 proteome (26 proteins) for the variants of concern and identify that the Delta variant harbors the highest mutational load in this proteome. Interestingly, the Delta variant's proteome is also highly diverse across different countries compared to the Alpha variant. Our observations suggest the need to account for country-specific mutational profiles for comprehensively understanding the biological attributes of the Delta variant such as increased viral loads and transmissibility, and reduced susceptibility against neutralization by vaccines. Currently, only the Spike protein mutations are being used in literature to define the SARS-CoV-2 variants of concern and interest 2,3 . However, the analysis of 1.99 million genome sequences of SARS-CoV-2 from 176 countries/territories in the GISAID database 4 revealed mutations in 52.3% of the 9757 amino-acid-long SARS-CoV-2 proteome. In all, there are 8157 unique mutations in 5107 amino acids spanning 24 of the 26 SARS-CoV-2 proteins ( Figure S1 ). The Spike protein contributes to only 6.3% (1055 unique mutations in 617 amino acids) of the mutated SARS-CoV-2 proteome, which emphasizes the need to study the mutational profile across all the proteins of SARS-CoV-2. Of the 1.99 million SARS-CoV-2 genomes analyzed here, there are 198,460 genomes corresponding to the Delta variant from 104 countries. We identified seven highly prevalent mutations in the following proteins of the Delta variant: Membrane (I82T: 99.9%), Nucleocapsid (R203M: 99.9%, D377Y: 99.6%), NSP12 (P323L: 99.9%), NS3 (S26L: 99.9%), and NS7a (V82A: 99.4%, T120I: 99.7%). Strikingly, all these mutations except P323L in NSP12 are nearly exclusive to the Delta variant compared to other variants of concern (mean prevalence Delta = 99.74%, mean prevalence otherVariantsofConcern = 0.12%) ( Figure S2, Table S1 ). Within the Spike protein, there are four such mutations (T19R, L452R, T478K, P681R) as well (mean prevalence Delta = 99.86%, mean prevalence otherVariantsofConcern = 0.04%). In total, there are ten mutations across the proteome that are characteristic of the Delta variant. This list of highly prevalent mutations can serve as candidates for probing the mechanistic basis of the Delta variant's pathogenic features such as high viral loads, increased transmissibility, and reduced susceptibility against neutralization by vaccines. Indeed, the I82T mutation of the SARS-CoV-2 Membrane protein of the Delta variant has been proposed previously to increase biological fitness with altered glucose uptake during viral replication 17 . The known functional implications of Delta variant mutations include antibody escape [18] [19] [20] [21] , high viral load 22 , increased transmissibility 7,23 , and infectivity 24 ( Table 1 ). While the Alpha variant spread widely during the pre-vaccination phase of the pandemic 3,25 , the Delta variant emerged as a global strain during the vaccination period. Given that the extent of vaccination coverage is highly variable across countries 26 , the selection pressure against the Delta variant is also likely to vary. To understand mutational profiles of SARS-CoV-2 variants of concern across countries, we generate 'mutational prevalence vectors' for each country of occurrence and calculate their pairwise cosine similarities (Figure 1A To determine mutations that can contribute to country-specific differences in the Delta variant, we identified the highly-prevalent mutations at the country level ("country-specific core mutations") (Figure 2A ; Methods). As an example, here we compare the country-specific core mutations in the United States (Delta UnitedStates ) and in India (Delta India ). Delta UnitedStates has 29 country-specific core mutations compared with 19 country-specific core mutations in Delta India ( Figure 2B ). Of these, 16 mutations are common, spanning structural proteins (Spike, Nucleocapsid, and Membrane), non-structural proteins (NSP3, NSP4, NSP6, NSP12, and NSP13), and accessory proteins (NS3, and NS7a). There are three mutations in three proteins that are highly prevalent in Delta India but not in Delta Unitedstates . In contrast, there are 13 mutations spanning six proteins that are highly prevalent in Delta UnitedStates but not Delta India , including in the exoribonuclease NSP14, which is critical for the viral replication machinery 27 and can inhibit the host translational machinery 28 . The presence of country-specific differences in the Delta variants motivate the need to understand whether these genome-level differences manifest differences in the disease phenotypes and vaccine effectiveness. COVID-19 is the first pandemic of the post-genomic era 29 that has been under intense genomic surveillance through concerted global viral sequencing efforts. This has led to the identification and tracking of emerging variants of concern, such as the highly transmissible Alpha variant and Delta variant. Through analysis of nearly 2 million genomes from 176 countries/territories, we have identified that there are mutations beyond the Spike protein that are characteristic of the Delta variant and that the Delta variant is more variable across countries than other variants of concern. Our study has identified ten highly prevalent mutations characteristic of the Delta variant across five proteins, which can serve as therapeutic targets and as candidates for probing the mechanistic basis of the Delta variant's pathogenic features such as high viral loads, increased transmissibility, and reduced susceptibility against neutralization by vaccines. The country-specific differences in the Delta variant's mutational profile identified in this study can also be used to guide the design of vaccines/boosters that can comprehensively combat COVID-19. Our study also motivates that the diversity at the proteome level should be considered in designating the variants of concern and interest. Future studies are warranted to comprehensively examine the combinations of factors such as vaccination rates, geographical proximity ( Figure S4) , and air connectivity ( Figure S5 ) to dissect the difference in the epidemiology of Delta variants across countries. This study has a few limitations. Since this study is based on publicly available data from the GISAID database, it may carry biases associated with sequencing disparities across countries and reporting delays. Though there is extensive genomic surveillance, there is a lack of clinical annotation of the genomes, limiting our ability to assess the clinical impact of the country-specific differences in the variants. The GISAID database does not record mutations in the recently discovered ORFs in the SARS-CoV-2 genome such as ORF10, ORF9b, and ORF9c. The assignment of the mutations in these ORFs may reveal further differences between SARS-CoV-2 variants. Though mass vaccination efforts are underway around the world, there are huge differences in the population immunity of countries due to the differences in the vaccines approved regionally and the extent of vaccination coverage in populations. These differences contribute to the risk of emergence of new SARS-CoV-2 variants and continued genome-surveillance is imperative for developing comprehensive global and country-specific preventive and therapeutic measures to end the ongoing pandemic. We retrieved 1,987,504 SARS-CoV-2 high coverage complete genome sequences from human hosts in 176 countries/territories spanning 1336 PANGO lineages on 18 August 2021 from GISAID 4 for December 2019 -July 2021, of which 816 sequences do not harbor any mutations. We removed sequences from other hosts and those with incomplete dates (YYYY-MM or YYYY) from further analyses. 1,986,688 sequences harbor a total of 89,875 unique mutations. However, to account for errors arising from sequencing, we only consider 8157 unique mutations in 24 proteins that are present in 100 or more sequences for all our further analyses. We did not identify any mutations in NSP11 (for which no mutations are present in 100 or more sequences) and ORF10 (for which no information on mutations are available in GISAID data), and hence are not considered in further analyses. Though 99.15% of all SARS-CoV-2 genome sequences possess one or more mutations in the Spike protein, 98.91% and 95.2% of sequences also bear mutations in the crucial NSP12 (RNA-dependent RNA polymerase, RdRp) and Nucleocapsid proteins, respectively. We retrieved the list of proteins in the SARS-CoV-2 proteome from NCBI 30 on 2 August 2021. The structure of the Spike protein was retrieved from PDB (code: 6VSB) and that of the structural models of the other SARS-CoV-2 proteins from https://zhanglab.ccmb.med.umich.edu/COVID-19/ (on 11 June 2021). To calculate the cosine similarity of a lineage L among countries, we generated a prevalence vector of constituent mutations for each country of occurrence of the lineage L. For a pair of countries, the cosine similarity of the lineage L was calculated for their mutation vectors (A, B) (Equation 1, Figure 1A) . The mean and standard deviation (S.D.) of pairwise cosine similarity values for variants of concern (mean Alpha = 0.94, S.D. Alpha where, M: mean, n: sample size, SD: standard deviation Probability distributions of pairwise cosine similarities were calculated by binning frequencies (bins = 25), and their Jensen-Shannon divergence (with base 2) was calculated using the jensenshannon function available in SciPy [v1.7.0] 31 . p-value was calculated using bootstrapping with 1000 iterations. To identify countries with similar mutational profiles, we clustered the pairwise cosine similarity matrix with Ward's variance minimization algorithm 32 available in SciPy [v1.7.0]. For each country, we resampled (with replacement) all the sequences deposited in the GISAID database and generated a cosine similarity distribution for Alpha and Delta variants ( Figure S6) . For calculating 95% confidence interval, we calculated Jensen-Shannon divergence (JSD) and Cohen's d for each bootstrap iteration. To get a null distribution for JSD and Cohen's d, we calculated these metrics from the Alpha and Delta cosine similarity distribution generated in each bootstrap iteration (n = 1000). The p-values were calculated based on the distribution of all bootstrapped values and original JSD / Cohen's d values. Air traffic data was accessed on 13 June 2021 from The OpenSky Network 2020 33, 34 . Only international flights were considered in this analysis. A matrix of the number of flights across all countries of the world was generated for the period of February 2021 -June 2021. For country A, a vector of the number of outgoing flights to all the other countries normalized with respect to the total number of outgoing flights from country A was generated. Similarly, for country B, a vector of the number of incoming flights from all the other countries normalized with respect to the total number of incoming flights to country B was generated. Cosine similarity for airline connectivity for this pair of countries was calculated as in Equation 1. Genome sequences of Alpha, Beta, Gamma, and Delta variants in GISAID data are available from 150, 95, 61, and 104 countries, respectively. For country C, we calculated the prevalence of a mutation M as in Equation 3. ( | ) = ℎ ℎ * 100 The prevalence of all mutations identified in lineage L in country C was calculated and further clustered using K-means clustering algorithm 35 (in scikit-learn 36 ) for unbiased identification of the highly prevalent set (core) of mutations for lineage L in country C. Based on K-means clustering sensitivity analysis, we partitioned the observations into two clusters for K-means clustering with initial cluster centroids at 0% and 100% ( Figure S7 ). All mutations with labels corresponding to the higher centroid are called the core mutations of lineage L in country C ("country-specific core mutations"). A union set of country-specific core mutations from all countries in which lineage L is present were also determined. We observed that the Delta variant's union set of country-specific core mutations are distinct and higher from those in the other variants of concern ( Figure S8, Table S2 ). The characteristic Spike protein mutations defined by the CDC 2 (as of 2 August 2021) overlap with those identified in our analysis (Figure S9) , thus validating our method of identifying mutations in the SARS-CoV-2 proteome. RS, PG, MJMN, GD, PA, VS, and AJV are employees of nference and have financial interests in the company and in the successful application of this research. nference collaborates with bio-pharmaceutical companies on data science initiatives unrelated to this study. These collaborations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VS and AJV conceived the study. PG, RS, MJMN and AJV designed the study, reviewed the findings and wrote the manuscript. RS, PG, MJMN, GD, PA, AJV and VS contributed methods, data, analysis, or software. All authors revised the manuscript. Figure 1: Schematic overview of the study. (A) Generation of country-specific mutation prevalence vectors and calculation of pairwise cosine similarity. The study dataset, updated as of 31 July 2021, with nearly 2 million sequences were retrieved from GISAID. For a variant of concern, mutational prevalence vectors were calculated for each country of their occurrence. (mean prevalence = 2.62%) in the other variants of concern. The Venn diagram shows the intersection and union set of country-specific core mutations among the two countries. The mutations are highlighted (in the same color scheme as the Venn diagram) on the structure of the Spike protein and the structural models of the other SARS-CoV-2 proteins (see Methods). Residues corresponding to Spike protein mutations T19R, T478K, and P681R are missing from the structure of the Spike protein and hence not shown here. The 43-amino acid long NS7b protein has no structure/model available and hence is not represented here. Table 1: Functional domain/region Is solvent-acc essible? Yes Antibody escape 18, 19 Spike_ΔF157 Yes Antibody escape 18, 19 Spike_ΔR158 Yes Antibody escape 18, 19 Spike_L452R Yes Antibody escape 20, 21 Spike_T478K Yes Antibody escape 20, 21 Spike_D614G -Yes Increases spike density and infectivity of virion 24 Country-specific core mutations for each variant of concern are calculated using a varying number of clusters (k) in the K-means algorithm. For each value of k, the Root Mean Square Error (RMSE) was calculated based on the distance of points from the centroid. The mean RMSE across all countries for each value of k has been plotted here. The dotted line represents the value of k (=2) selected for further analyses. The different repertoire of mutations in the variants of concern. Each tick on the x-axis represents a mutation and is annotated in magenta if it is a part of the union set of country-specific core mutations for the variant. (B) Comparison of union sets of country-specific core mutations across different variants of concern. 136 out of 155 (87.74%) mutations in the Delta variant are unique to it. (C) Distribution of country-specific core mutation counts across countries for the variants of concern. The median count of country-specific core mutations for each variant is indicated on the plot. The Delta variant has a higher mutational load as compared to the other variants of concern. Figure S9: Union set of country-specific core mutations in Spike protein of SARS-CoV-2 variants. Comparison of country-specific core Spike mutations versus characteristic Spike mutations. Venn diagrams show a comparison of core Spike mutations identified in this study versus characteristic Spike mutations reported by CDC for each variant of concern. We failed to identify ΔL241 from the CDC's set, which can be attributed to the differential alignment of the deleted positions to the wild-type SARS-CoV-2 genome in the mutation calling pipeline of the genomic assembly. In contrast, we identified multiple mutations in the Spike protein for each lineage that are highly prevalent in one or more countries but are missing from CDC's set of mutations. Table S2 : List of the union set of country-specific core mutations unique to the Delta variant's proteome. This table lists the union set of country-specific core mutations (136), across 104 countries, which are unique to the proteome of the Delta variant (as in Figure S8B ). Spike (S) T19R, K77T, T95I, G142D, E156G, ΔE156, ΔF157, R158G, ΔR158, R214H, P251L, D253A, L452R, T478K, E484Q, T572I, D574Y, Q677H, P681R I251M, A596T NSP3 A85V, P192L, T422I, A488S, T678I, I707V, H727R, V765F, P778S, P822L, E906D, V1070I, P1103Q, T1189I, L1244F, G1273S, H1274Y, A1311V, P1469S, I1723V, A1736V, T1830I NSP4 S137L, V167L, T204I, D217N, V293I, C296F, F375S, T492I NSP5 I213V NSP8 K37N, L122I NSP10 A104V NSP6 A2V, H11Q, T77A, V149A, T181I NSP12 K91R, M124I, F192V, M196I, R197Q, G228S, D269G, D481A, T644M, G671S, T801I, M818V NSP13 P77L, V187L, V210I, I334V NSP14 T16I, P46L, M49I, M72I, A119V, V182I, I363V, A394V, Y420stop NSP15 K109N, H234Y, R257C, K259R, M330I NSP16 P215L, R216N, R216C, Q238H NS3 S92L, A110S, E239D NS6 K48N NS8 A65S, S69L, I88T, L95F COVID-19 map -johns Hopkins Coronavirus resource Center SARS-CoV-2 Variant Classifications and Definitions Tracking SARS-CoV-2 variants Global initiative on sharing all influenza data -from vision to reality COVID-19 Virtual Press conference transcript -12 Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant COVID vaccines slash viral spread -but Delta is an unknown Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum SARS-CoV-2 protein datasets -NCBI Datasets Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens Cell entry mechanisms of SARS-CoV-2 Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization Spike mutation D614G alters SARS-CoV-2 fitness Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity The UK has approved a COVID vaccinehere's what scientists now want to know Tracking Coronavirus Vaccinations Around the World The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2 Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein COVID-19, the first pandemic in the post-genomic era SARS-CoV-2 protein datasets -NCBI Datasets SciPy 1.0: fundamental algorithms for scientific computing in Python Application of an Hierarchical Grouping Procedure to a Problem of Grouping Profiles Crowdsourced air traffic data from The OpenSky Network 2020 Crowdsourced air traffic data from the OpenSky Network Least squares quantization in PCM Scikit-learn: Machine learning in Python. the How the coronavirus infects cells -and why Delta is so dangerous Characterizing SARS-CoV-2 mutations in the United States The authors thank Murali Aravamudan, Arjun Puranik, Sutirtha Chakraborty, Gajinder Pal Singh and Shahir Asfahan for feedback on this manuscript.